📰 Athersys Inc News
Page 16 - Athersys Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Athersys Inc. Real-time updates on events, politics, business and more.
August 9, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global tissue engineering market is estimated to be valued at US$ 9,436.0 million in 2022 and is...
August 4, 2022
The Cleveland-based regenerative medicine company announced Thursday, Aug. 4, that it has named turnaround consultant Kasey Rosado to the interim CFO role. Ivor Macleod, the company's former CFO, left Athersys on June 30 as part of a restructuring announced in early June that is cutting the workforce by 70%.
July 8, 2022
The Cleveland biotechnology company said it will 'evaluate alternative financing options to support continuing operations' following an announcement of the termination of its $100 million equity purchase agreement with Aspire.
June 25, 2022
A look at the most prominent Northeast Ohio business stories of the past week.
June 21, 2022
The Cleveland-based regenerative medicine company, which is undertaking cost-cutting and restructuring efforts, cut the size of the board of directors in half ahead of the annual meeting of shareholders. That meeting will take place on Thursday, July 28.
June 10, 2022
Athersys (NASDAQ: ATHX) recently received a number of ratings updates from brokerages and research firms: 6/8/2022 – Athersys was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of […]
June 9, 2022
Webinar scheduled for June 14, 2022 at 5:00 p.m. ETCLEVELAND--(BUSINESS WIRE)--$ATHX #investorconference--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a panel discussion with leading neurology experts...
June 9, 2022
The Cleveland-based regenerative medicine company is moving the meeting back by about six weeks, to July 28, as it considers implementing a reverse stock split and makes changes to its board of directors.
June 8, 2022
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Anti-aging Therapeutics Market (Type of Molecule...
June 8, 2022
JERSEY CITY, N.J., June 8, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Anti-aging Therapeutics Market (Type of Molecule (Biologics